Obesity trials in Germany

In Germany 85 Also abroad 1939

85 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
HUGO-SLEEVE: Evaluating the Feasibility of Robotic Sleeve Gastrectomy With a New Platform
Where
Hamburg
Age
18 years and over
People
50
Run by
Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT07884994
Phase 4Taking people
Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide
Where
Munich
Age
18 years to 60 years
People
150
Run by
Technical University of Munich
See details and how to joinNCT07777575 · EU 2026-526200-69-00
Phase 3Taking people
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
Where
Berlin, Essen, Hanover
Age
18 years and over
People
549 worldwide
Run by
Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526336-39-00 · EU 2026-526336-39-00
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Bad Oeynhausen, Bochum, Cologne, Dresden, Falkensee, Gera, Hamburg, Leipzig, Lübeck, Mainz, Mannheim, München, Münster, Nuremberg, Obertshausen, Oldenburg, Stuttgart, Ulm, Wangen, Würzburg
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Taking people
A Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
Where
Berlin, Bochum, Bünde, Dresden, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Offenbach Am Main, Schwerin
Age
18 years and over
People
420 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524616-11-00 · EU 2025-524616-11-00
Phase 3Taking people
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Where
Bochum, Hamburg, Hanover, Karlsruhe, Muenster, Schleswig
Age
18 years and over
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07571109 · EU 2024-520443-16-00
Phase 1Taking people
A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity
Where
Berlin
Age
18 years and over
People
320
Run by
Novo Nordisk A/S
See details and how to joinNCT07815067 · EU 2025-521383-35-00
Phase 3Not yet taking people in Germany
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Aachen, Bad Oeynhausen, Berlin, Dessau, Dresden, Elsterwerda, Essen, Frankfurt Am Main, Freiburg im Breisgau, Hamburg, Hanover, Karlsruhe, Köln-Dünnwald, Leipzig, Luebeck, Mainz, Reichelsheim, Stuttgart, Traunstein, Villingen-Schwenningen, Wallerfing, Wuerzburg
Age
45 years to 64 years
People
8,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
Phase 3Taking people
Maridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea on Positive Airway Pressure Therapy (MARITIME-OSA-1)
Where
Berlin, Essen, Hamburg, Hanover, Karlsruhe, Oldenburg in Holstein
Age
18 years and over
People
115 worldwide
Run by
Amgen Inc.
See details and how to join2025-522703-14-00 · EU 2025-522703-14-00
No phaseTaking people
Combining Fasting and Fibre Interventions to Optimise Their Gut Microbiome-mediated Health Benefits
Where
Überlingen
Age
18 years to 65 years
People
75
Run by
Buchinger Wilhelmi Development & Holding GmbH
See details and how to joinNCT07691736
No phaseNot yet taking people in Germany
NutrImmune: Precision Nutrition to Improve Immunity in Individuals With Obesity
Where
Stuttgart
Age
40 years to 70 years
People
168 worldwide
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07850206
No phaseTaking people
Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes
Where
Nuthetal
Age
18 years to 75 years
People
30
Run by
German Institute of Human Nutrition
See details and how to joinNCT07171281
Phase 3Taking people
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Where
Cologne, Leipzig, Ulm
Age
12 years to 17 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06439277
Phase 3Taking people
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Where
Bad Oeynhausen, Elsterwerda, Fulda, Magdeburg, Osnabrück, Witten
Age
18 years and over
People
1,150 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07339423 · EU 2024-520440-42-00
Phase 1Taking people
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity
Where
Mannheim
Age
18 years to 74 years
People
70
Run by
Boehringer Ingelheim
See details and how to joinNCT07754474 · EU 2026-526090-42-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Dresden, Duisburg, Essen, Hamburg, Köln, Leipzig, Lingen, Mainz, Mannheim, Oldenburg in Holstein, Wangen im Allgäu
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
Phase 3Taking people
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Where
Berlin, Essen, Hanover
Age
18 years and over
People
1,560 worldwide
Run by
Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743450
Phase 3Taking people
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Where
Berlin, Essen, Hanover, Leipzig
Age
18 years and over
People
3,003 worldwide
Run by
Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743463
No phaseTaking people
Validation of Energy Expenditure Measures Study
Where
Leipzig
Age
18 years to 65 years
People
49
Run by
University of Leipzig
See details and how to joinNCT07155564
No phaseTaking people
Exercise, Chronotype, and Prediabetes
Where
Düsseldorf
Age
19 years to 75 years
People
28
Run by
German Diabetes Center
See details and how to joinNCT07389005
Phase 3Taking people
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Where
Bochum, Hamburg, Hanover, Karlsruhe, Muenster, Schleswig
Age
18 years and over
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07571005 · EU 2024-520442-36-00
Phase 1/2Taking people
A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D
Where
Neuss
Age
18 years to 75 years
People
188
Run by
Gubra A/S
See details and how to joinNCT07702890 · EU 2025-524921-42-00
Phase 3Taking people
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
Where
Bad Oeynhausen, Bochum, Cologne, Dresden, Falkensee, Gera, Hamburg, Köln, Leipzig, Luebeck, Mainz, Mannheim, Muenster, München, Nürnberg, Obertshausen, Oldenburg in Holstein, Stuttgart, Ulm, Wangen im Allgäu, Wuerzburg
Age
18 years and over
People
1,010 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524688-19-00 · EU 2025-524688-19-00
Phase 1Taking people
A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF COR-1389
Where
Neuss
Age
18 years to 64 years
People
140
Run by
Corteria Pharmaceuticals
See details and how to join2024-514853-31-00 · EU 2024-514853-31-00
No phaseTaking people
Shift Workers' Health Behavior Action Program Across Europe
Where
Bremen, Bremerhaven
Age
21 years and over
People
400 worldwide
Run by
Wageningen University
See details and how to joinNCT07631767